:format(jpeg)/cloudfront-us-east-1.images.arcpublishing.com/gfrmedia/KM54W4X4ABFJPHNDKVIYKJYEHA.jpg)
Norgestrel, the first oral contraceptive approved for use in the United States without a prescription and marketed under the name Opill, is on sale online starting this Mondayannounced the pharmaceutical company Perrigo.
”Since privacy is important to Perrigo, Opill will be shipped in boxes without prints or brands,” Sara Young, the firm’s vice president, explained in an email, adding that orders will be delivered in one or two days.
The contraceptive, which has already been sent to pharmacy chains, is available in one-month boxes for $19.99, three-month boxes for $49.99, and six-month boxes for $89.99.
Norgestrel is not new. It has been on the market for half a century as a prescription contraceptive until 2023. Food and Drug Administration (FDA) determined that it is safe for sale without that requirement in the country. These 75 milligram pills are oral contraceptives that must be administered at the same time each day and should not be used as emergency contraception.
According to the FDA, used as directed, Opill is up to 98% effective in preventing pregnancy. The FDA still recommends additional methods to prevent pregnancy, such as using condoms when a woman misses taking Opill daily or takes it more than three hours after the usual time.
This additional access to pregnancy prevention comes as abortion has become one of the most controversial issues in the November presidential campaign. In June 2022, the Supreme Court annulled at the federal level a 1973 ruling that had legalized the procedure and since then twenty states have passed laws that restrict it.
The FDA warns that women who have or have had breast cancer, if they are already pregnant, or in combination with other birth control methods such as a different pill, the vaginal ring, implants, or intrauterine device, should not take Opill.
